This protocol addresses the initial management of episcleritis in patients for whom treatment is indicated. It follows a structured, evidence-based approach.
When treatment is required, the initial approach involves a specific topical ophthalmic eye drop administered on a regular daily schedule. The full regimen — including the agent, dosing schedule, and monitoring — is detailed in the complete protocol.
DOI: 10.1016/S0002-9394(00)00710-8
For patients requiring treatment, the initial treatment for episcleritis typically consisted of fluoromethalone 1% eye drops four times daily.
View source ↗